CFHR5 and atypical hemolytic-uremic syndrome: Genetic variants in CFHR5 have been detected in patients with complement-mediated kidney disease such as aHUS [19, 20], C3 glomerulopathy, and immune complex-associated membranoproliferative glomerulonephritis [17, 26].